TOP2B
Summary: This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
DNA topoisomerase II beta | MIM:126431 | Ensembl:ENSG00000077097 | HGNC:HGNC:11990 | PA36672 | 3p24.2 |
GO terms in TOP2B
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0003677 | DNA binding |
MF | IDA | GO:0003682 | chromatin binding |
MF | IDA | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity |
MF | IPI | GO:0005080 | protein kinase C binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IPI | GO:0008022 | protein C-terminus binding |
MF | IPI | GO:0019899 | enzyme binding |
MF | IPI | GO:0042826 | histone deacetylase binding |
MF | IEA | GO:0046872 | metal ion binding |
MF | IPI | GO:0046982 | protein heterodimerization activity |
BP | IBA | GO:0000712 | resolution of meiotic recombination intermediates |
BP | IBA | GO:0000819 | sister chromatid segregation |
BP | IEA | GO:0001764 | neuron migration |
BP | IDA | GO:0006265 | DNA topological change |
BP | IEA | GO:0007409 | axonogenesis |
BP | IEA | GO:0030900 | forebrain development |
BP | IBA | GO:0044774 | mitotic DNA integrity checkpoint |
CC | IDA | GO:0000792 | heterochromatin |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005730 | nucleolus |
CC | IDA | GO:0005829 | cytosol |
CC | ISS | GO:1990904 | ribonucleoprotein complex |
Gene expression in normal tissue: TOP2B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TOP2B
Database | Pathway ID | Pathway Des. |
---|---|---|
smpdb | SMP00442 | Etoposide Action Pathway |
smpdb | SMP00601 | Etoposide Metabolism Pathway |
pharmgkb | PA165292164 | Doxorubicin Pathway (Cardiomyocyte Cell), Pharmacodynamics |
pharmgkb | PA2025 | Etoposide Pathway, Pharmacokinetics/Pharmacodynamics |
reactome | R-HSA-2990846 | SUMOylation |
reactome | R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-4615885 | SUMOylation of DNA replication proteins |
reactome | R-HSA-597592 | Post-translational protein modification |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD330 | BRD4132 | 4 |
iGMDRD599 | Salermide | 2 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD144 | NSC95397 | 4 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD523 | Cyanoquinoline, 11 | 2 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD85 | Ursolic acid | 1 |
iGMDRD351 | GW843682X | 2 |
iGMDRD394 | BX-795 | 1 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD221 | Tamoxifen | 2 |
iGMDRD192 | CIL56 | 3 |
iGMDRD782 | DC-45-A2 | 3 |
iGMDRD434 | BMS-536924 | 3 |
iGMDRD441 | TW 37 | 2 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD52 | Rotenone | 4 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD286 | Nsc 632839 | 4 |
iGMDRD871 | BRD6368 | 2 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD662 | JQ-1 | 2 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD147 | Prima-1 | 1 |
iGMDRD369 | TGX-115 | 2 |
iGMDRD268 | Cerulenin | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in TOP2B